Drug Testing, Prosecution Focus of Racing Conference

A seminar focused on drug testing and the prosecution of a medication case will be the focus of the Racing Officials Accreditation Program’s second annual Officiating Horse Racing Conference on Dec. 7, 2009, at the University of Arizona Race Track Industry Program’s Symposium on Racing and Gaming at the Westin La Paloma Resort in Tucson, Ariz.

The year’s conference is geared especially for assistant attorneys general and presenters of evidence, racing commission counsel, investigators, stewards and racing commissioners. Presentations and discussions will cover virtually every aspect of drug case prosecution, including:

  • Sample collection and documentation
  • Interpreting the analytical data
  • Understanding toxicology and pharmacology
  • Due process
  • Drug classification and potential to affect performance
  • Expert witnesses and testimony
  • Case presentation
  • Developing trends in drugs and testing

Racing industry attorney Alan Foreman will lead the conference. Foreman is vice chairman of the Racing Medication and Testing Consortium and counsel to the United States Equestrian Federation’s Drugs and Medications Program.

Other faculty include Ira Finkelstein, an equine law attorney and partner in Harnik and Finkelstein in New York; George Maylin, DVM, PhD, director of the New York State Racing and Wagering Board Equine Drug Testing and Research Program at Cornell University; Scott Stanley, PhD, director of the Kenneth L. Maddy Equine Analytical Laboratory at the University of California-Davis; and Scot Waterman, DVM, executive director of the Racing Medication and Testing Consortium.

Disclaimer: Seek the advice of a qualified veterinarian before proceeding with any diagnosis, treatment, or therapy.